Cancer Moonshot Report Describes Initial Success, Remaining Challenges

The Cancer Moonshot initiative has been successful in drawing private-sector partners for improving data-sharing among researchers, but the project has yet to mature.

By | October 19, 2016


The White House issued a report Monday (October 18) on the progress of US Vice President Joe Biden’s Cancer Moonshot initiative, an ambitious effort to accelerate cancer research. The report lays out broad goals for the initiative over the next two years, including supporting innovation, establishing private-sector partnerships, and fostering collaboration.

Congress has yet to approve $700 million of the project’s $1 billion budget, Reuters reports.

Among its accomplishments so far, the Cancer Moonshot has secured a partnership between the National Cancer Institute, Amazon, and Microsoft to provide cloud-based data-sharing for cancer researchers, according to a White House press release. It has also struck deals with ride-sharing services Uber and Lyft to provide affordable transportation for cancer patients to and from treatment.

Under the initiative, a cohort of government, academic, and industry representatives are also launching the Blood Profiling Atlas Pilot, an open-access database of liquid biopsy data. The database is intended to facilitate development of blood diagnostic technology by providing larger datasets than are accessible to individual institutions.

President Obama announced the $1 billion Moonshot initiative during his State of the Union address in January this year, expressing the goal of accomplishing a decade’s worth of cancer research progress in five years. In September, a panel of experts assembled by the Moonshot provided 10 recommended scientific objectives, which are included in Monday’s report.

“I'm going to devote the rest of my life to working on this, and I think we're perilously close to making some gigantic progress,” Biden told reporters Monday, according to Reuters

Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo


Avatar of: mlerman


Posts: 71

October 19, 2016

I solved the cancer problem: 1.To prevent cancer daily use a dose of aromatic sulfonamide inhibitor/dorzolamide/. 2. To cure cancer use combined gene therapy with VHL gene delivered to cancer stem cells, and FUS1 gene delivered to hematopoietic stem cell (HPSC) Michael Lerman, PhD, MD  
Avatar of: cirotora


Posts: 1

April 18, 2017

We have been successfully building on Merck's hypothesis that hypoxia is a key driver for the start and spread of many cancers and their resistance to conventional therapy. An eight-year Translational Observation study has been informally recording significant successes with artificially intelligent direct oxygen infusion at the cellular level that appears to be a safe and effective therapy. This documentation is supported by numerous formal medical records generated by independent Board Certified Oncologists.

Our researchers were invited as Key Note Speakers to the Advanced Cancer Diagnostic and Therapy Congress in London last year. Our presentation advances a fundamental shift in understanding and treating cancer:  

“Hypoxic micro-environments, a primary driver of uncontrollable tumor growth and resistance to standard treatments.

1.  Merck has identified hypoxia as a key element in the growth and spread of many solid tumors, therefore, direct molecular oxygen infusion would appear to be an effective means of cancer control,

2.  Until now there has been no practical or effective means of precisely delivering active oxygen molecules directly to cancer cells,

3.  Artificially intelligent hunter-killer direct oxygen infusion nano-clusters can actively seek out individual cancer cells and directly infuse them with an overload of active oxygen molecules, destroying them instantly.”

 For detailed information please contact me at Thank you


Popular Now

  1. 2017 Top 10 Innovations
    Features 2017 Top 10 Innovations

    From single-cell analysis to whole-genome sequencing, this year’s best new products shine on many levels.

  2. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  3. Antiviral Immunotherapy Comes of Age
    News Analysis Antiviral Immunotherapy Comes of Age

    T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 

  4. Search for Life on the Red Planet